Drug Database
Back to search

France· FR:61469681

ARIXTRA 10 mg/0,8 ml, solution injectable en seringue pré-remplie

A fondaparinux product containing fondaparinux sodique, registered in France by VIATRIS HEALTHCARE (IRLANDE), on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC B01AX05

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedARIXTRA 10 mg/0,8 ml, solution inject…ATCB01AX05REGISTER NO.FR:61469681PACKS LISTED2CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fondaparinux sodiqueAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Fondaparinux is registered in 17 of 19 countries.

Countries holding a registration under ATC B01AX05 (fondaparinux), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 11 of them publish a price we can compare per daily dose
Search fondaparinux products by name

Fondaparinux · ATC B01AX05

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
FONDAPARINUX SODIQUE
Manufacturer
VIATRIS HEALTHCARE (IRLANDE)
Country
France (FR)
ATC code
B01AX05
ATC class
Fondaparinux
Defined daily dose
2.5 mg, P
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400936565340
    2 seringue(s) préremplie(s) en verre de 0,8 ml avec aiguille(s)
    EUR 24.89
  • cip13
    3400936565579
    10 seringue(s) préremplie(s) en verre de 0,8 ml avec aiguille(s)
    EUR 122.96

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

158 interactions on record for fondaparinux.

Graded by severity as the source publishes them — 106 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check fondaparinux against other medicinesHow interaction checks work

Fondaparinux · interactions on record

158 records

  • 106 severe
  • 52 moderate

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • Antithrombin IIIB01AB02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fondaparinux in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fondaparinux products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Germany · Fondaparinux-Natrium Beta
  • United Kingdom (Northern Ireland) · Fondaparinux Sodium Dr. Reddy's
  • Ireland · Fondaparinux Sodium Aspen
  • Iceland · Arixtra
  • Liechtenstein · Arixtra
  • Norway · Arixtra

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b56da9e1-dcf5-4d08-b817-ca11637a58c1
GET /v1/drugs/b56da9e1-dcf5-4d08-b817-ca11637a58c1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61469681",
  "date_amm": "2004-11-12",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/02/206",
  "substance": "FONDAPARINUX SODIQUE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "sous-cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about fondaparinux.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console